VERACYTE, INC. Accrued Marketing Costs, Current
VERACYTE, INC. (VCYT) had Accrued Marketing Costs, Current of $0 as of 2016-12-31, per its 10-K filed 2017-03-01.
Discontinued › Notes › Accrued Liabilities, Current
us-gaap:AccruedMarketingCostsCurrent · last filed 2017-03-01
- 2016-12-31: Accrued Marketing Costs, Current $0.00.
- 2016-09-30: Accrued Marketing Costs, Current $0.00.
- 2016-06-30: Accrued Marketing Costs, Current $2.18M.
- 2016-03-31: Accrued Marketing Costs, Current $2.06M.
| Period end | Accrued Marketing Costs, Current |
|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-01 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-03 |
| 2016-06-30 | $2.18M 10-Q · filed 2016-08-03 |
| 2016-03-31 | $2.06M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $2.09M 10-K · filed 2017-03-01 |
| 2015-09-30 | $1.84M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $1.69M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $1.68M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $3.31M 10-K · filed 2016-03-14 |
| 2014-09-30 | $3.21M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $2.72M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $2.78M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $4.92M 10-K · filed 2015-03-25 |
| 2013-09-30 | $2.32M 10-Q · filed 2013-11-25 |
| 2012-12-31 | $2.17M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |